Published date: 27 May 2022

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 7 February 2022, 1pm

Contract summary

Industry

  • Pharmaceutical products - 33600000

  • Pharmacy services - 85149000

Location of contract

LS2 7UE

Value of contract

£0 to £1

Procurement reference

CF-0869500D0O000000rwimUAA1

Published date

27 May 2022

Closing date

7 February 2022

Closing time

1pm

Contract start date

2 May 2022

Contract end date

1 August 2023

Contract type

Service contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole. The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority. In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only.

Award information

Awarded date

28 April 2022

Contract start date

2 May 2022

Contract end date

1 August 2023

Total value of contract

£1

This contract was awarded to 1 supplier.

Accord-UK Ltd

Address

Whiddon Valley, Barnstaple, Devon, EX32 8NS, Barnstaple, EX32 8NS

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Contact name

Liz Fleetwood

Address

Quarry Hill
Leeds
LS2 7UE
GB

Email

liz.fleetwood1@nhs.net